BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 27, 2026
Home » Authors » Sergio Held

Articles by Sergio Held

Venezuelan med-tech guild confronts non-responsive government

Feb. 25, 2016
By Sergio Held

Embattled Sientra gets ready to go back to work after certification debacle

Feb. 16, 2016
By Sergio Held
BOGOTA, Colombia — After facing an unprecedented crisis last year, breast implants company Sientra Inc. reported that it is ready to resume its commercial activities next month.
Read More

Looking to Replace traditional syringes :Mexican millennials developing futuristic med-tech products

Feb. 5, 2016
By Sergio Held

Steba enters LatAm, files MAA in Europe for prostate cancer drug

Jan. 28, 2016
By Sergio Held

Steba enters LatAm, files MAA in Europe for prostate cancer drug

Jan. 28, 2016
By Sergio Held
BOGOTA, Colombia – After 12 years in relative stealth mode, Steba Biotech, a Luxembourg-based company owned by Israeli shareholders is launching operations in Latin America and submitted a marketing authorization application (MAA) to the EMA for Tookad, seeking approval to market the drug for the treatment of localized prostate cancer.
Read More

Silimed issues still not resolved: Sientra's new CEO updates physicians over crisis with Brazilian operations

Jan. 13, 2016
By Sergio Held

HPV vaccine under fire in Brazil; MFP files action requesting ban

Jan. 8, 2016
By Sergio Held
BOGOTA, Colombia – Multinational manufacturers of human papillomavirus (HPV) vaccines are getting ready to defend the effectiveness of the product in Brazil after a public attorney set out to ban them across the country.
Read More

Eurofarma looking for opportunities to expand into Africa, Asia, U.S.

Dec. 30, 2015
By Sergio Held
BOGOTA, Colombia – Brazilian pharma major Eurofarma is looking to expand its footprint by tapping into markets in Africa, investing in the U.S. and reaching deeper into Latin America markets through new plants, the acquisition of established businesses and by introducing new products.
Read More

Tijuana's med-tech sector enjoyed much success in 2015

Dec. 29, 2015
By Sergio Held

Prostate diagnosis kits: Mdxhealth enters LatAm market with Uruguayan partner Southgenetics

Dec. 22, 2015
By Sergio Held
Previous 1 2 … 13 14 15 16 17 18 19 20 21 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 24, 2026.
  • Cell nucleus architecture

    4D Nucleome opens new wave of gene regulation research, discovery

    BioWorld
    After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
  • Drug capsule spilling onto brain

    Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s

    BioWorld Science
    Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
  • Business pipeline illustration

    Transcripta Bio raises funding to advance neuro pipeline

    BioWorld Science
    Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
  • Other news to note for July 22, 2026

    BioWorld
    Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing